Product How it works Pricing Blog FAQ About Contact
Haemonetics

Haemonetics (NYSE: HAE) net income

Haemonetics reported a net profit of $97.3m for fiscal 2026, 42.0% less than in fiscal 2025 ($167.7m). Its net margin was 7.3%. Earnings per share were $2.06.

Haemonetics's best year of the last 10 was fiscal 2025. The biggest drop was in fiscal 2022, −45.4%. It reported a loss in 1 of those 10 years.

Net income, in millions of US dollars-26.3201745.6201855.0201976.5202079.5202143.42022115.42023117.62024167.7202597.32026
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2026$97.3m−42.0%7.3%$2.06
2025$167.7m+42.6%12.3%$3.33
2024$117.6m+1.9%9.0%$2.32
2023$115.4m+166.1%9.9%$2.27
2022$43.4m−45.4%4.4%$0.85
2021$79.5m+3.8%9.1%$1.57
2020$76.5m+39.1%7.7%$1.51
2019$55.0m+20.7%5.7%$1.07
2018$45.6m—5.0%$0.86
2017−$26.3m—−3.0%−$0.51

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Haemonetics net income compared with its sector

By net income for its latest fiscal year, Haemonetics ranks 114th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Haemonetics, 7.3%.

RankCompanyNet incomeNet margin
112thPhibro Animal Health$99.7m6.6%
113thAmphastar Pharmaceuticals$98.1m13.6%
114thHaemonetics$97.3m7.3%
115thAddus HomeCare$95.9m6.7%
116thEmbecta$95.4m8.8%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Haemonetics

How much did Haemonetics earn in fiscal 2026?
Haemonetics reported a net profit of $97.3m for fiscal 2026. In fiscal 2025 it reported a net profit of $167.7m.
What are the earnings per share of Haemonetics?
They were $2.06 in fiscal 2026, compared with $3.33 in fiscal 2025.
What is the net margin of Haemonetics?
In fiscal 2026 its net profit was 7.3% of its revenue.
What was the most profitable year for Haemonetics?
Of its last 10 fiscal years, fiscal 2025, with $167.7m.
Where does Haemonetics rank in its sector by net income?
It ranks 114th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Haemonetics come from?
From the annual report (Form 10-K) that Haemonetics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Haemonetics files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Haemonetics: the Haemonetics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.